Lazard Asset Management’s ANI Pharmaceuticals ANIP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,781
| Closed | -$97K | – | 2297 |
|
|
2024
Q4 | $97K | Sell |
1,781
-3,819
| -68% | -$208K | ﹤0.01% | 1801 |
|
|
2024
Q3 | $333K | Sell |
5,600
-1,235
| -18% | -$73.4K | ﹤0.01% | 1492 |
|
|
2024
Q2 | $434K | Buy |
+6,835
| New | +$434K | ﹤0.01% | 1254 |
|
|
2024
Q1 | – | Sell |
-3,022
| Closed | -$166K | – | 2031 |
|
|
2023
Q4 | $166K | Hold |
3,022
| – | – | ﹤0.01% | 1456 |
|
|
2023
Q3 | $175K | Buy |
3,022
+495
| +20% | +$28.7K | ﹤0.01% | 1435 |
|
|
2023
Q2 | $135K | Buy |
+2,527
| New | +$135K | ﹤0.01% | 1464 |
|
|
2023
Q1 | – | Sell |
-1,371
| Closed | -$55K | – | 2284 |
|
|
2022
Q4 | $55K | Buy |
+1,371
| New | +$55K | ﹤0.01% | 1758 |
|
|
2016
Q2 | – | Sell |
-65,073
| Closed | -$2.19M | – | 1039 |
|
|
2016
Q1 | $2.19M | Buy |
65,073
+3,683
| +6% | +$124K | ﹤0.01% | 599 |
|
|
2015
Q4 | $2.77M | Buy |
+61,390
| New | +$2.77M | 0.01% | 607 |
|